Inosine, 99% 肌苷
CAS 58-63-9 MFCD00066770
信息真实价格透明
资金保障
专业采购外包团队在线服务
信息真实价格透明
资金保障
专业采购外包团队在线服务
品牌质保精细包装
现货库存
一流品牌服务
分类
- Bases & Related Reagents
- Nucleotides
- {SNA} Other Biochemical, Phytochemicals by Chemical Classification, 细胞生物学, 营养研究
- {SNA} Cell Biology, Metabolic Pathways, Metabolites and Cofactors on the Metabolic Pathways Chart, Metabolomics, Nucleotide, Nutrition Research, Other Biochemical, Phytochemicals by Chemical Classification
- {SA} Nutrition Research, Other Biochemical,
- {SNA} Nutrition Research, Other Biochemical, Phytochemicals by Chemical Classification
- {SNA} Metabolic Pathways, Metabolites and Cofactors on the Metabolic Pathways Chart, Nucleotide, Other Biochemical, Phytochemicals by Chemical Classification, 代谢组学, 细胞生物学, 营养研究
- {SNA} Nucleotide,
产品应用
- 肌苷是神经生产因子(NGF)潜在的刺激因子。
相关文献及参考
- [2]. Francisney Pinto Nascimento, et al. Adenosine A1 receptor-dependent antinociception induced by inosine in mice: pharmacological, genetic and biochemical aspects. Mol Neurobiol. 2015;51(3):1368-78.
- [3]. Ajith A. Welihinda, et al. The adenosine metabolite inosine is a functional agonist of the adenosine A2A receptor with a unique signaling bias. Cell Signal. 2016 Jun; 28(6): 552-560.
- [4]. Sara Cipriani, et al. Protection by inosine in a cellular model of Parkinson’s disease. Neuroscience. 2014 Aug 22; 274: 242-249.
- Merck:14,4975
- Merck:14,4975 Beilstein:31,25
- Nestor, G., et al.: J. Agric. Food Chem., 58, 10799 (2010),
- Short: EINECS
- Short: III/10a
- Short: III/20a
- Vandemeulebroucke, A., et al.: Biochem., 49, 8999 (2010),
- [1]. Filipe Marques Gonçalves, et al. Signaling pathways underlying the antidepressant-like effect of inosine in mice. Purinergic Signal. 2017 Jun; 13(2): 203-21
安全信息
GHS Symbol
- S24/25 Avoid contact with skin and eyes 避免皮肤和眼睛接触;
- R36/37/38 Irritating to eyes, respiratory system and skin 对眼睛、呼吸系统和皮肤有刺激性
- P262 Do not get in eyes, on skin, or on clothing. 不要接触眼睛,皮肤或衣服。
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 3175 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : PCJOAU Pharmaceutical Chemistry Journal (English Translation). Translation of KHFZAN. (Plenum Pub. Corp., 233 Spring St., New York, NY 10013) No.1- 1967- Volume(issue)/page/year: 20,160,1986
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intraperitoneal SPECIES OBSERVED : Rodent - rat DOSE/DURATION : 2900 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,77,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Oral SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >20 gm/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: 6,77,1982
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Intravenous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : >2800 mg/kg TOXIC EFFECTS : Details of toxic effects not reported other than lethal dose value REFERENCE : NIIRDN Drugs in Japan (Ethical Drugs). (Yakugyo Jiho Co., Ltd., Tokyo, Japan) Volume(issue)/page/year: -,156,1995
TYPE OF TEST : LD50 - Lethal dose, 50 percent kill ROUTE OF EXPOSURE : Subcutaneous SPECIES OBSERVED : Rodent - mouse DOSE/DURATION : 5 gm/kg TOXIC EFFECTS : Details of toxic effects not
TYPE OF TEST : DNA damage TEST SYSTEM : Mammal - species unspecified Lymphocyte DOSE/DURATION : 60 mmol/L REFERENCE : PNASA6 Proceedings of the National Academy of Sciences of the United States of America. (National Academy of Sciences, Printing & Pub. Office, 2101 Constitution Ave., Washington, DC 20418) V.1- 1915- Volume(issue)/page/year: 48,686,1962
其他信息
- 用途五:肌苷是神经生产因子(NGF)潜在的刺激因子。
- Acros Organic
- 用途一:生化研究。医药用于促进白细胞增长
- 用途三:参与体内能量代谢和蛋白质的合成。可用于治疗由于各种原因引起的白细胞减少、血小板减少等。可引起轻度腹泻,不能与乳清酸、氯霉素、潘生丁及硫喷妥钠注射液配伍。
- 方法一:方法一、肌苷酸脱磷酸法 肌苷酸二钠的制备 棒状杆菌269发酵,发酵液去菌体,吸附,洗脱,浓缩,加乙醇,pH7-7.5条件下结晶可得肌苷酸二钠。 棒状杆菌269[发酵]→发酵液[去菌体,吸附,洗脱,浓缩]→浓缩液[乙醇]→[pH7-7.5]肌苷酸二钠 肌苷粗品的制备 在乙酸缓冲液中,调pH5.4-5.6,加压137-147kPa,脱磷酸5h,可得肌苷粗品。 肌苷酸二钠[乙酸,加压]→肌苷 精制 蒸馏水溶解,pH=6,重结晶,可得精品。 方法二、一步发酵法 菌株选育 变异芽孢杆菌7171-9-1移接到斜面培养基上,30-32℃培养48h。斜面培养基成分为葡萄糖1%,蛋白胨0.4%,酵母浸膏0.7%,牛肉浸膏1.4%,琼脂2%,在pH7、120℃灭菌20min。 变异芽孢杆菌7171-9-1[斜面培养]→[30-32℃, 48h]菌种斜面 种子培养 一级种子:培养基成分为葡萄糖2%,蛋白胨1%,酵母浸膏1%,玉米浆0.5%,尿素0.5%,氯化钠0.25%。灭菌前pH 7,用1L三角瓶装150ml培养基,115℃灭菌15min。每个三角瓶中接入白金耳环菌苔,在往复式摇床上,32℃±1℃培养18h。 二级种子:培养基同一级种子,放大50L发酵罐,定容体积25L,接种量 3%,32℃±1℃培养12-15h,搅拌速度320r/min,通风量1:0.25V/(V·min),生长菌指标 A(650nm)=0.78,pH=6.4-6.6。 菌种斜面[摇床振荡]→[pH7, 32℃±1℃, 18h]一级种子培养液[50L发酵罐]→[pH6.4-6.6, 32℃±1℃, 12-15h]二级种子培养液 发酵 50L不锈钢标准发酵罐,定容体积35L。培养基成分为淀粉水解糖10%,干酵母水解液1.5%,豆饼水解液0.5%,尿素0.4%,硫酸镁0.1%,氯化钾0.2%,磷酸氢二钠0.5%,硫酸铵1.5%,有机硅油0.05%。pH=7,接种量0.9%,32℃±1℃培养93h,搅拌速度320r/min,通风量1:0.5V/(V·min)。500L发酵罐,定容体积350L。培养基成分为淀粉水解糖10%,干酵母水解液1.5%,豆饼水解液0.5%,硫酸铵1.5%,硫酸镁0.1%,氯化钾0.2%,磷酸氢二钠0.5%,碳酸钙1%,有机硅油小于0.3%。pH=7,接种量7%,32℃±1℃培养75h,搅拌速度230r/min,通风量1:0.25V/(
- 用途二:用作辅酶类药物
- TC
- 比旋光度:-49.2 ° (c=1,H2O 18 °C)
- 用途四:本品几乎无毒性和副作用,能直接透过细胞膜进入人体细胞,使处于人低能、缺氧状态下的细胞能继续顺利地进行代谢,并能活化丙酮酸氧化酶类,参与人体蛋白质的合成。主要用于各种类型的肝疾病、心疾患、白血球减少症、血小板减小、中心性视网膜炎以及预防和解除锑剂引起的副作用。
- 下游产品:DL-色氨酸 --> 利巴韦林 --> 5'-核糖核苷酸钙 --> 地达诺辛 --> 四乙酰核糖
- Sigma Aldrich:58-63-9(sigmaaldrich)
- {Chemica
- 方法二:肌苷可通过直接发酵法生产,也可通过半合成法生产。半合成法采用发酵制得的甩苷酸二钠为原料,经脱膦而得肌苷。
- 图谱信息:肌苷(58-63-9)红外图谱(IR2) 肌苷(58-63-9)核磁图( 1 HNMR) 肌苷(58-63-9)红外图谱(IR1) 肌苷(58-63-9)质谱(MS) 肌苷(58-63-9)核磁图( 13 CNMR)
- 肌苷价格(试剂级):更新日期 产品编号 产品名称 包装 价格 2011/08/23 65009733 肌苷;次黄嘌呤核苷;9-β-D-呋喃核糖基次黄嘌呤 10g 37.1元 2011/04/16 I0037 肌苷 Inosine 500G 5390元 2011/04/16 I0037 肌苷 Inosine 25G 580元